RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. [electronic resource]
Producer: 20131126Description: 3944-53 p. digitalISSN:- 1476-5594
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Biphenyl Compounds -- pharmacology
- Blotting, Western
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Enzyme Activation -- drug effects
- Fibroblast Growth Factor 2 -- genetics
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Neuroblastoma -- genetics
- Nitrophenols -- pharmacology
- Oligonucleotide Array Sequence Analysis
- Piperazines -- pharmacology
- Protein Kinase C-delta -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Pyrroles -- pharmacology
- RNA Interference
- Receptor, Fibroblast Growth Factor, Type 2 -- antagonists & inhibitors
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Sulfonamides -- pharmacology
- bcl-X Protein -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.